" /> " />

Edwards Lifesciences Earnings Estimate

EW Stock  USD 95.56  0.41  0.43%   
The next projected EPS of Edwards Lifesciences is estimated to be 0.64 with future projections ranging from a low of 0.63 to a high of 0.66. Edwards Lifesciences' most recent 12-month trailing earnings per share (EPS TTM) is at 2.31. Please be aware that the consensus of earnings estimates for Edwards Lifesciences Corp is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Edwards Lifesciences is projected to generate 0.64 in earnings per share on the 31st of March 2024. Edwards Lifesciences earnings estimates module stress-tests analyst consensus about projected Edwards Lifesciences Corp EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. Many public companies, such as Edwards Lifesciences, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Edwards Lifesciences' earnings estimates, investors can diagnose different trends across Edwards Lifesciences' analyst sentiment over time as well as compare current estimates against different timeframes. At this time, Edwards Lifesciences' Gross Profit is fairly stable compared to the past year. Net Profit Margin is likely to climb to 0.25 in 2024, whereas Pretax Profit Margin is likely to drop 0.14 in 2024.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edwards Lifesciences Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing.

Edwards Lifesciences Earnings Estimation Breakdown

The calculation of Edwards Lifesciences' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Edwards Lifesciences is estimated to be 0.64 with the future projection ranging from a low of 0.63 to a high of 0.66. Please be aware that this consensus of annual earnings estimates for Edwards Lifesciences Corp is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
0.64
0.63
Lowest
Expected EPS
0.64
0.66
Highest

Edwards Lifesciences Earnings Projection Consensus

Suppose the current estimates of Edwards Lifesciences' value are higher than the current market price of the Edwards Lifesciences stock. In this case, investors may conclude that Edwards Lifesciences is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Edwards Lifesciences' stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of March 2024Current EPS (TTM)
2198.42%
0.64
0.64
2.31

Edwards Lifesciences Earnings History

Earnings estimate consensus by Edwards Lifesciences Corp analysts from Wall Street is used by the market to judge Edwards Lifesciences' stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Edwards Lifesciences' upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.

Edwards Lifesciences Quarterly Gross Profit

1.18 Billion

At this time, Edwards Lifesciences' Retained Earnings are fairly stable compared to the past year. Retained Earnings Total Equity is likely to climb to about 9.2 B in 2024, whereas Price Earnings Ratio is likely to drop 31.34 in 2024. Net Income Applicable To Common Shares is likely to climb to about 1.8 B in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 550.8 M in 2024.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Edwards Lifesciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
93.4695.5697.66
Details
Intrinsic
Valuation
LowRealHigh
86.00105.97108.07
Details
Naive
Forecast
LowNextHigh
93.5495.6397.73
Details
31 Analysts
Consensus
LowTargetHigh
83.1191.33101.38
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Edwards Lifesciences. Your research has to be compared to or analyzed against Edwards Lifesciences' peers to derive any actionable benefits. When done correctly, Edwards Lifesciences' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Edwards Lifesciences Corp. Note that many institutional investors and large investment bankers can move markets due to the volume of Edwards assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards Edwards Lifesciences. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving Edwards Lifesciences' stock price in the short term.

Edwards Lifesciences Earnings per Share Projection vs Actual

Actual Earning per Share of Edwards Lifesciences refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Edwards Lifesciences Corp predict the company's earnings will be in the future. The higher the earnings per share of Edwards Lifesciences, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Edwards Lifesciences Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Edwards Lifesciences, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Edwards Lifesciences should always be considered in relation to other companies to make a more educated investment decision.

Edwards Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Edwards Lifesciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-02-06
2023-12-310.640.640.0
2023-10-25
2023-09-300.590.590.0
2023-07-26
2023-06-300.650.660.01
2023-04-26
2023-03-310.610.620.01
2023-01-31
2022-12-310.610.640.03
2022-10-27
2022-09-300.620.61-0.01
2022-07-28
2022-06-300.640.63-0.01
2022-04-26
2022-03-310.570.60.03
2022-01-26
2021-12-310.550.51-0.04
2021-10-27
2021-09-300.530.540.01
2021-07-29
2021-06-300.560.640.0814 
2021-04-20
2021-03-310.470.540.0714 
2021-01-27
2020-12-310.530.5-0.03
2020-10-21
2020-09-300.440.510.0715 
2020-07-23
2020-06-300.170.340.17100 
2020-04-23
2020-03-310.440.50.0613 
2020-01-30
2019-12-310.50.49-0.01
2019-10-23
2019-09-300.410.470.0614 
2019-07-23
2019-06-300.440.460.02
2019-04-23
2019-03-310.410.440.03
2019-01-31
2018-12-310.390.390.0
2018-10-23
2018-09-300.340.360.02
2018-07-26
2018-06-300.380.410.03
2018-04-24
2018-03-310.370.410.0410 
2018-02-01
2017-12-310.30.310.01
2017-10-24
2017-09-300.290.28-0.01
2017-07-26
2017-06-300.290.320.0310 
2017-04-25
2017-03-310.270.310.0414 
2017-02-01
2016-12-310.240.250.01
2016-10-25
2016-09-300.230.230.0
2016-07-26
2016-06-300.230.250.02
2016-04-26
2016-03-310.220.240.02
2016-02-02
2015-12-310.210.210.0
2015-10-26
2015-09-300.160.180.0212 
2015-07-28
2015-06-300.180.190.01
2015-04-23
2015-03-310.170.190.0211 
2015-02-03
2014-12-310.160.180.0212 
2014-10-23
2014-09-300.120.130.01
2014-07-29
2014-06-300.130.150.0215 
2014-04-24
2014-03-310.120.130.01
2014-02-03
2013-12-310.140.150.01
2013-10-28
2013-09-300.110.110.0
2013-07-25
2013-06-300.130.140.01
2013-04-23
2013-03-310.130.12-0.01
2013-02-04
2012-12-310.130.150.0215 
2012-10-19
2012-09-300.090.10.0111 
2012-07-24
2012-06-300.110.110.0
2012-04-24
2012-03-310.080.090.0112 
2012-02-02
2011-12-310.10.10.0
2011-10-19
2011-09-300.070.06-0.0114 
2011-07-21
2011-06-300.080.080.0
2011-04-20
2011-03-310.070.090.0228 
2011-02-02
2010-12-310.090.090.0
2010-10-25
2010-09-300.070.070.0
2010-07-21
2010-06-300.070.080.0114 
2010-04-20
2010-03-310.070.070.0
2010-02-04
2009-12-310.070.070.0
2009-10-21
2009-09-300.060.060.0
2009-07-20
2009-06-300.060.070.0116 
2009-04-27
2009-03-310.060.060.0
2009-02-03
2008-12-310.060.070.0116 
2008-10-21
2008-09-300.050.050.0
2008-07-22
2008-06-300.050.060.0120 
2008-04-22
2008-03-310.040.050.0125 
2008-02-05
2007-12-310.040.050.0125 
2007-10-22
2007-09-300.040.040.0
2007-07-23
2007-06-300.050.050.0
2007-04-23
2007-03-310.050.050.0
2007-02-05
2006-12-310.040.050.0125 
2006-10-19
2006-09-300.040.040.0
2006-07-24
2006-06-300.040.050.0125 
2006-04-20
2006-03-310.040.040.0
2006-02-02
2005-12-310.040.040.0
2005-10-25
2005-09-300.040.040.0
2005-07-21
2005-06-300.040.040.0
2005-04-21
2005-03-310.040.040.0
2005-01-27
2004-12-310.040.040.0
2004-10-21
2004-09-300.030.030.0
2004-07-27
2004-06-300.030.040.0133 
2004-04-22
2004-03-310.030.030.0
2004-02-03
2003-12-310.030.040.0133 
2003-10-20
2003-09-300.030.030.0
2003-07-22
2003-06-300.030.030.0
2003-04-22
2003-03-310.030.030.0
2003-02-03
2002-12-310.030.030.0
2002-10-22
2002-09-300.030.030.0
2002-07-23
2002-06-300.030.030.0
2002-04-23
2002-03-310.030.030.0
2002-02-05
2001-12-310.020.020.0
2001-10-25
2001-09-300.020.020.0
2001-07-26
2001-06-300.020.020.0
2001-04-26
2001-03-310.020.020.0
2001-02-06
2000-12-310.020.020.0
2000-10-31
2000-09-300.020.020.0
2000-08-24
2000-06-300.010.010.0

About Edwards Lifesciences Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Edwards Lifesciences earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Edwards Lifesciences estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Edwards Lifesciences fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for 2024
Retained EarningsB9.4 B
Retained Earnings Total Equity8.7 B9.2 B
Price Earnings Ratio 32.99  31.34 
Price Earnings To Growth Ratio(5.41)(5.14)

Edwards Lifesciences Investors Sentiment

The influence of Edwards Lifesciences' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Edwards. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Edwards Lifesciences' public news can be used to forecast risks associated with an investment in Edwards. The trend in average sentiment can be used to explain how an investor holding Edwards can time the market purely based on public headlines and social activities around Edwards Lifesciences Corp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Edwards Lifesciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Edwards Lifesciences' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Edwards Lifesciences' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Edwards Lifesciences.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Edwards Lifesciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Edwards Lifesciences' short interest history, or implied volatility extrapolated from Edwards Lifesciences options trading.

Pair Trading with Edwards Lifesciences

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Edwards Lifesciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edwards Lifesciences will appreciate offsetting losses from the drop in the long position's value.

Moving together with Edwards Stock

  0.89BSX Boston Scientific Corp Financial Report 24th of April 2024 PairCorr
  0.68COO Cooper Companies Financial Report 6th of June 2024 PairCorr

Moving against Edwards Stock

  0.86MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr
  0.81PHG Koninklijke Philips Financial Report 22nd of April 2024 PairCorr
  0.73MBIO Mustang Bio Report 3rd of April 2024 PairCorr
  0.71PIIIW P3 Health PartnersPairCorr
  0.69TFX Teleflex Incorporated Financial Report 2nd of May 2024 PairCorr
The ability to find closely correlated positions to Edwards Lifesciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Edwards Lifesciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Edwards Lifesciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Edwards Lifesciences Corp to buy it.
The correlation of Edwards Lifesciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Edwards Lifesciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Edwards Lifesciences Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Edwards Lifesciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Edwards Lifesciences Corp is a strong investment it is important to analyze Edwards Lifesciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Edwards Lifesciences' future performance. For an informed investment choice regarding Edwards Stock, refer to the following important reports:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edwards Lifesciences Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Complementary Tools for Edwards Stock analysis

When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Is Edwards Lifesciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Edwards Lifesciences. If investors know Edwards will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Edwards Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.06)
Earnings Share
2.31
Revenue Per Share
9.897
Quarterly Revenue Growth
0.138
Return On Assets
0.1225
The market value of Edwards Lifesciences Corp is measured differently than its book value, which is the value of Edwards that is recorded on the company's balance sheet. Investors also form their own opinion of Edwards Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Edwards Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Edwards Lifesciences' market value can be influenced by many factors that don't directly affect Edwards Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Edwards Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Edwards Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Edwards Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.